Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-06

Clinical Trial Update: Rheumatoid Arthritis Memory B Cells and Abatacept [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating abatacept's impact on memory B cells in rheumatoid arthritis; results were posted on 2023-02-06.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORENCIA (ABATACEPT)

Snippet

Sponsor: NYU Langone Health | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2023-02-06